457 / 1031
Treatment approach
I
Aupérin (2010) benefit of concurrent radiochemotherapy
regarding overall survival (5.7% @ 3 yrs, 4.5% @ 5 yrs)
I
Higher treatment-related toxicity
(4% seq vs 18% concurr)
h h d
d
ld
I
W ic ra iation ose wou you give?
www.uniklinikum-dresden.de